Literature DB >> 19185646

Contrast-enhanced magnetic resonance imaging identifies focal regions of intramyocardial fibrosis in patients with severe aortic valve disease: Correlation with quantitative histopathology.

Marcelo Nigri1, Clerio F Azevedo, Carlos Eduardo Rochitte, Vladimir Schraibman, Flavio Tarasoutchi, Pablo M Pommerantzeff, Carlos Manuel Brandão, Roney O Sampaio, José R Parga, Luiz F Avila, Guilherme S Spina, Max Grinberg.   

Abstract

BACKGROUND: Chronic aortic valve disease (AVD) is characterized by progressive accumulation of interstitial myocardial fibrosis (MF). However, assessment of MF accumulation has only been possible through histologic analyses of endomyocardial biopsies. We sought to evaluate contrast-enhanced magnetic resonance imaging (ce-MRI) as a noninvasive method to identify the presence of increased MF in patients with severe AVD.
METHODS: Seventy patients scheduled to undergo aortic valve replacement surgery were examined by cine and ce-MRI in a 1.5-T scanner. Cine images were used for the assessment of left ventricular (LV) volumes, mass, and function. Delayed-enhancement images were used to characterize the regions of MF. In addition, histologic analyses of myocardial samples obtained during aortic valve replacement surgery were used for direct quantification of interstitial MF. Ten additional subjects who died of noncardiac causes served as controls for the quantitative histologic analyses.
RESULTS: Interstitial MF determined by histopathologic analysis was higher in patients with AVD than in controls (2.7% +/- 2.0% vs 0.6% +/- 0.2%, P = .001). When compared with histopathologic results, ce-MRI demonstrated a sensitivity of 74%, a specificity of 81%, and an accuracy of 76% to identify AVD patients with increased interstitial MF. There was a significant inverse correlation between interstitial MF and LV ejection fraction (r = -0.67, P < .0001). Accordingly, patients with identifiable focal regions of MF by ce-MRI exhibited worse LV systolic function than those without MF (45% +/- 14% vs 65% +/- 14%, P < .0001).
CONCLUSIONS: Contrast-enhanced MRI allows for the noninvasive detection of focal regions of MF in patients with severe AVD. Moreover, patients with identifiable MF by ce-MRI exhibited worse LV functional parameters.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19185646     DOI: 10.1016/j.ahj.2008.09.012

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  18 in total

1.  Calculations of cardiovascular shunts and regurgitation using magnetic resonance ventricular volume and aortic and pulmonary flow measurements.

Authors:  Daniel G H Devos; Philip J Kilner
Journal:  Eur Radiol       Date:  2009-08-29       Impact factor: 5.315

Review 2.  Aortic valvular imaging with cardiovascular magnetic resonance: seeking for comprehensiveness.

Authors:  Gianluca De Rubeis; Nicola Galea; Isabella Ceravolo; Gian Marco Dacquino; Iacopo Carbone; Carlo Catalano; Marco Francone
Journal:  Br J Radiol       Date:  2019-07-18       Impact factor: 3.039

Review 3.  Cardiac imaging in patients with chronic kidney disease.

Authors:  Diana Y Y Chiu; Darren Green; Nik Abidin; Smeeta Sinha; Philip A Kalra
Journal:  Nat Rev Nephrol       Date:  2015-01-06       Impact factor: 28.314

Review 4.  Assessment of myocardial fibrosis with cardiovascular magnetic resonance.

Authors:  Nathan Mewton; Chia Ying Liu; Pierre Croisille; David Bluemke; João A C Lima
Journal:  J Am Coll Cardiol       Date:  2011-02-22       Impact factor: 24.094

5.  T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy.

Authors:  Christopher T Sibley; Radwa A Noureldin; Neville Gai; Marcelo Souto Nacif; Songtao Liu; Evrim B Turkbey; James O Mudd; Rob J van der Geest; João A C Lima; Marc K Halushka; David A Bluemke
Journal:  Radiology       Date:  2012-10-22       Impact factor: 11.105

6.  Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.

Authors:  Lian-Ming Wu; Bing-Hua Chen; Qiu-Ying Yao; Yang-Rongzheng Ou; Rui Wu; Meng Jiang; Jiani Hu; Dong-Aolei An; Jian-Rong Xu
Journal:  Int J Cardiovasc Imaging       Date:  2016-05-19       Impact factor: 2.357

Review 7.  Multimodality imaging for the quantitative assessment of mitral regurgitation.

Authors:  Pei G Chew; Katrina Bounford; Sven Plein; Dominik Schlosshan; John P Greenwood
Journal:  Quant Imaging Med Surg       Date:  2018-04

Review 8.  The role of cardiovascular magnetic resonance in the assessment of severe aortic stenosis and in post-procedural evaluation following transcatheter aortic valve implantation and surgical aortic valve replacement.

Authors:  Tarique Al Musa; Sven Plein; John P Greenwood
Journal:  Quant Imaging Med Surg       Date:  2016-06

Review 9.  Evaluation of the aortic and mitral valves with cardiac computed tomography and cardiac magnetic resonance imaging.

Authors:  Sung Min Ko; Meong Gun Song; Hweung Kon Hwang
Journal:  Int J Cardiovasc Imaging       Date:  2012-11-09       Impact factor: 2.357

10.  Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T.

Authors:  Christophe de Meester de Ravenstein; Caroline Bouzin; Siham Lazam; Jamila Boulif; Mihaela Amzulescu; Julie Melchior; Agnès Pasquet; David Vancraeynest; Anne-Catherine Pouleur; Jean-Louis J Vanoverschelde; Bernhard L Gerber
Journal:  J Cardiovasc Magn Reson       Date:  2015-06-11       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.